(Q38019969)

27 August 2017

title

Off-label uses of trazodone: a review (English)

1 reference

27 August 2017

5

Andrea Fagiolini

1 reference

27 August 2017

Letizia Bossini

1

1 reference

27 August 2017

Ilaria Casolaro

series ordinal

2

1 reference

27 August 2017

Despoina Koukouna

series ordinal

3

1 reference

27 August 2017

Federica Cecchini

series ordinal

4

1 reference

27 August 2017

language of work or name

English

0 references

publication date

20 June 2012

1 reference

Expert Opinion on Pharmacotherapy

27 August 2017

published in

1 reference

27 August 2017

volume

13

1 reference

27 August 2017

issue

12

1 reference

27 August 2017

page(s)

1707-1717

1 reference

Mechanism of action of trazodone: a multifunctional drug

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone ameliorates nightmares in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone for erectile dysfunction: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Safety of trazodone as a sleep agent for inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Complete heart block following a single dose of trazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

QT Prolongation and delayed atrioventricular conduction caused by acute ingestion of trazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Sleep problems in the community elderly as predictors of death and nursing home placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Sleep in the Elderly: Burden, Diagnosis, and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone enhances sleep in subjective quality but not in objective duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone for antidepressant-associated insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

The effects of trazodone on sleep disturbances induced by brofaromine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone for the treatment of sleep disorders in dementia: an open-label, observational and review study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone in the treatment of panic disorder and agoraphobia with panic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Efficacy of trazodone as an anti obsessional agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone for the treatment of fibromyalgia: an open-label, 12-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone for Alzheimer's disease: a naturalistic follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Pharmacologic strategies for discontinuing benzodiazepine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Adjuvant trazodone in the treatment of alcoholism: an open study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Treatment of sleep disturbance in alcohol recovery: a national survey of addiction medicine physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

A naturalistic study of trazodone in the treatment of behavioral complications of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Frontotemporal dementia: a randomised, controlled trial with trazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Role of mirtazapine in the treatment of antipsychotic-induced akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Chronic pain: hypothesized mechanism and rationale for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Problems associated with long-term treatment with selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

The safety of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.699523

10.1517/14656566.2012.699523

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference